These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 14903183)

  • 1. Effects of mescaline and lysergic acid (d-LSD-25).
    HOCH PH; CATTELL JP; PENNES HH
    Am J Psychiatry; 1952 Feb; 108(8):579-84. PubMed ID: 14903183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
    SANGUINETI I; NEGRI VU; LARICCHIA R
    Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychophysical correlations. VIII. Experimental tests in schizophrenia; lysergic acid diethylamide and mescaline].
    FISCHER R; GEORGI F; WEBER R
    Schweiz Med Wochenschr; 1951 Sep; 81(35):837-40. PubMed ID: 14866109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychophysical correlations. VIII. Experimental tests in schizophrenia: lysergic acid diethylamide and mescaline].
    FISCHER R; GEORGI F; WEBER R
    Schweiz Med Wochenschr; 1951 Aug; 81(34):817-9; contd. PubMed ID: 14866104
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical reactions of schizophrenics to sodium amytal, pervitin hydrochloride, mescaline sulfate, and d-lysergic acid diethylamide (LSD25).
    PENNES HH
    J Nerv Ment Dis; 1954 Feb; 119(2):95-112. PubMed ID: 13163687
    [No Abstract]   [Full Text] [Related]  

  • 6. Mescaline and LSD-25 in activation of temporal lobe epilepsy.
    SCHWARZ BE; BICKFORD RG; MULDER DW; ROME HP
    Neurology; 1956 Apr; 6(4):275-80. PubMed ID: 13309607
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible biosynthesis of D-lysergic acid diethylamide-like compounds from mescaline.
    FISCHER R
    Experientia; 1955 Apr; 11(4):162-3. PubMed ID: 14380263
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148).
    GINZEL KH; MAYER-GROSS W
    Nature; 1956 Jul; 178(4526):210. PubMed ID: 13348662
    [No Abstract]   [Full Text] [Related]  

  • 9. The cerebral electrographic changes induced by LSD and mescaline are corrected by frenquel.
    RINALDI F; HIMWICH HE
    J Nerv Ment Dis; 1955 Nov; 122(5):424-32. PubMed ID: 13320138
    [No Abstract]   [Full Text] [Related]  

  • 10. Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy.
    FREDERKING W
    J Nerv Ment Dis; 1955 Mar; 121(3):262-6. PubMed ID: 14381913
    [No Abstract]   [Full Text] [Related]  

  • 11. Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis; preliminary note on its clinical application.
    FABING HD
    Neurology; 1955 May; 5(5):319-28. PubMed ID: 14370384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Variations of the cholinergic activity of the cerebral cortex tissue caused by bulbocapnine, lysergic acid diethylamide and mescaline].
    POLONI A; MAFFEZZONI G
    Sist Nerv; 1952; 4(6):578-81. PubMed ID: 13048791
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
    Van Vunakis H; Farrow JT; Gjika HB; Levine L
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1483-7. PubMed ID: 5283939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mescaline, LSD-25, and adrenochrome on depth electrograms in man.
    SCHWARZ BE; SEM-JACOBSEN CW; PETERSEN MC
    AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):579-87. PubMed ID: 13325988
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intoxication with mescalin and diethylamid of lysergic acid; autoexperiments with special consideration of a drawing test].
    MATEFI L
    Confin Neurol; 1952; 12(3):146-77. PubMed ID: 14936391
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychological and biochemical effects of lysergic acid diethylamide.
    MAYER-GROSS W; McADAM W; WALKER JW
    Nature; 1951 Nov; 168(4280):827-8. PubMed ID: 14890764
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies in human cerebral function: the effects of mescaline and lysergic acid on cerebral processes pertinent to creative activity.
    BERLIN L; GUTHRIE T; WEIDER A; GOODELL H; WOLFF HG
    J Nerv Ment Dis; 1955 Nov; 122(5):487-91. PubMed ID: 13320148
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on human cerebral function: the effects of mescaline and lysergic acid on cerebral processes pertinent to creative activity.
    BERLIN L; GUTHRIE T; WEIDER A; GOODELL H; WOLFF HG
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):188-90. PubMed ID: 13312038
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology of mescaline and D-lysergic acid diethylamide (LSD).
    KOELLE GB
    N Engl J Med; 1958 Jan; 258(1):25-32. PubMed ID: 13493730
    [No Abstract]   [Full Text] [Related]  

  • 20. VISUAL HALLUCINATIONS WITH IMIPRAMINE.
    KLEIN DF
    Am J Psychiatry; 1965 Mar; 121():911-4. PubMed ID: 14264768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.